Syntax Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$275K Buy
546
+21
+4% +$10.3K 0.24% 91
2023
Q2
$252K Sell
525
-64
-11% -$31.3K 0.2% 115
2023
Q1
$278K Buy
589
+78
+15% +$37.6K 0.21% 90
2022
Q4
$271K Sell
511
-48
-9% -$25.4K 0.23% 91
2022
Q3
$282K Sell
559
-2
-0.4% -$1.05K 0.24% 86
2022
Q2
$288K Buy
561
+23
+4% +$11.6K 0.24% 87
2022
Q1
$274K Sell
538
-233
-30% -$112K 0.23% 99
2021
Q4
$387K Buy
+771
New +$349K 0.29% 65

Other funds holding UNH

Syntax Advisors's UNH Position: Q3 2023 in Review

Syntax Advisors increased its UnitedHealth (UNH) stake by 4% in Q3 2023, buying an estimated $10.3K and bringing the position to 546 shares worth $275K. The position accounts for 0.24% of the portfolio, ranked #91.

Syntax Advisors first reported a position in UNH in Q4 2021 and has held it in 8 quarters since. The position peaked at $387K in Q4 2021. 3,137 funds tracked by Wall St. Rank hold UNH as of Q3 2023.

  • Syntax Advisors held 546 shares of UnitedHealth worth $275K as of Q3 2023.
  • Syntax Advisors bought 21 UnitedHealth shares in Q3 2023, an estimated $10.3K.
  • UnitedHealth made up 0.24% of Syntax Advisors's portfolio in Q3 2023, its #91 holding.
  • Syntax Advisors first reported a position in UnitedHealth in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's UnitedHealth position peaked at $387K in Q4 2021.
  • 3,137 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.